avi-4065
Nucleic acidexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2005 (NCT00229749)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Hepatitis C virusANTISENSE INHIBITOR
Hepatitis C virus antisense inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- avi-4065
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00381433 | Phase 1 | Sep 1, 2006 | NW Kinetics, Sarepta Therapeutics |
| NCT00229749 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2005 | Sarepta Therapeutics, Stanford University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sarepta Therapeutics | For profit | 2 | 2 | 2 | 2005 |
| NW Kinetics | For profit | 1 | 0 | 1 | 2006 |
| Stanford University | Academic/Hospital | 1 | 0 | 1 | 2005 |
3 organizations
Page 1 / 1